Dr. Joseph C. Masdeu, MD, PhD

Dr. Masdeu practices at Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas.

Dr. Masdeu's NPI, 1376853770, was assigned on October 19, 2010. Dr. Masdeu graduated from Complutense University of Madrid in 1969. Dr. Masdeu holds Texas license Q4804.

Dr. Masdeu's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD, at 6550 Fannin St, Houston, TX 77030.

Dr. Masdeu's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas. Dr. Masdeu is also affiliated with Houston Methodist Hospital. The medical group on file is Houston Methodist Specialty Physician Group. Dmand AI also links Dr. Masdeu to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Masdeu practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Masdeu's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Masdeu is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Masdeu's licenses on file in 3 states: Texas, New York and Illinois.

Dmand AI lists alzheimer's disease, cerebrovascular disease and non-alzheimer's dementia (chronic) among the conditions Dr. Masdeu treats.

CMS data shows 331 Medicare services from Dr. Masdeu across 4 procedure codes in 2024, all of them office visits, for 208 Medicare patients. Medicare paid $39,929 for them. Every service was in an office.

CMS counts 208 Medicare patients who saw Dr. Masdeu in 2024. The largest group is 75 to 84, with 110 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Masdeu's median patient age at 77, with 56% women.

In 2024, Dr. Masdeu wrote 1,039 Medicare Part D claims for 204 patients. 94% of them were for generic drugs. CMS names the drug for 916 of them, across 15 drugs with 11 or more claims each, at $209,029 in total drug cost. In 2023, CMS named 995 claims across 19 drugs.

Dr. Masdeu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Masdeu as offering telehealth.

Dmand AI links 145 papers to Dr. Masdeu, published from 2006 to 2025. 2022 was the busiest year, with 6. The most frequent topics are Brain, Magnetic Resonance Imaging and Diagnosis, Differential. Dr. Masdeu has published most often in Radiology. Dr. Masdeu's most frequent co-authors are Stephen Jory Pomeranz, MD, David Jay Seidenwurm, MD and Thomas John Masaryk, MD.

Dmand AI links Dr. Masdeu to 9 clinical trials. 2 are still active or recruiting. Conditions studied include Alzheimer Disease, Tauopathies and Brain Concussion. Eli Lilly and Company sponsors the most, 6. Open Payments lists research payments to Dr. Masdeu that name 6 trials.

CMS Open Payments shows 352 general payments to Dr. Masdeu from 39 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 45% of the total. Eli Lilly and Company paid the most, $66,187. It also lists 20 research payments totaling $76,290 from 2016 to 2023, naming 6 clinical trials.

Dr. Masdeu graduated from Complutense University of Madrid in 1969.

Dr. Masdeu is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.